RAPID QUANTITATIVE-DETERMINATION OF EPIRUBICIN AND ITS METABOLITES IN PLASMA USING HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY AND FLUORESCENCE DETECTION

被引:13
作者
DINE, T [1 ]
BRUNET, C [1 ]
LUYCKX, M [1 ]
CAZIN, M [1 ]
GOSSELIN, P [1 ]
CAZIN, JL [1 ]
机构
[1] CTR OSCAR LAMBRET,RADIOPHARM & PHARM CLIN LAB,F-59020 LILLE,FRANCE
关键词
D O I
10.1002/bmc.1130040103
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
A rapid sensitive and selective isocratic technique was developed for the analysis of plasma epirubicin and three of its known fluorescent metabolites epirubicinol, 4′‐O‐β‐D‐glucuronyl‐4′‐epidoxorubicin and 4′‐O‐β‐D‐glucuronyl 1,3‐dihydro‐4′‐epidoxorubicin, with daunorubicin as an internal standard, by using high performance liquid chromatography (HPLC) with fluorescence detection and a ‘Hypersil ODS’ column. The drugs were easily and efficiently extracted with a Sep‐Pak C18 cartridge and the mean recoveries were greater than 85%. Intraassay and Interassay coefficients of variation (plasma samples) were better than 8.25%. An example of pharmacokinetic study obtained in a cancer patient after intravenous injection of epirubicine is described. Copyright © 1990 John Wiley & Sons, Ltd.
引用
收藏
页码:20 / 23
页数:4
相关论文
共 20 条
  • [1] BONFANTE V, 1979, CANCER TREAT REP, V63, P915
  • [2] ANALYSIS OF ADRIAMYCIN AND ADRIAMYCINOL IN MICRO VOLUMES OF RAT PLASMA
    BOTS, AMB
    VANOORT, WJ
    NOORDHOEK, J
    VANDIJK, A
    KLEIN, SW
    VANHOESEL, QGCM
    [J]. JOURNAL OF CHROMATOGRAPHY, 1983, 272 (02): : 421 - 427
  • [3] CAMAGGI CM, 1985, DRUG EXP CLIN RES, V11, P285
  • [4] CAMAGGI CM, 1982, CANCER TREAT REP, V66, P1819
  • [5] CAMAGGI CM, 1988, CANCER CHEMOTH PHARM, V21, P216
  • [6] CASAZZA AM, 1979, CANCER TREAT REP, V63, P835
  • [7] CAZIN J L, 1987, Journal de Pharmacie Clinique, V6, P585
  • [8] CEROSIMO RJ, 1986, CLIN ONCOL, V4, P425
  • [9] COMPARATIVE PHARMACOKINETIC STUDY OF ADRIAMYCIN AND 4'EPI-ADRIAMYCIN AFTER THEIR SIMULTANEOUS INTRAVENOUS ADMINISTRATION
    EKSBORG, S
    STENDAHL, U
    LONROTH, U
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1986, 30 (05) : 629 - 631